Beta-adrenergic blockers for the control of aggressive behaviors in patients with chronic schizophrenia.
The authors conducted a chart review to determine the effect of beta blockers on chronic assaultiveness in seven patients with chronic schizophrenia. Six of the patients showed improvement. Four of the seven showed a greater than 70% decrease in actual assaults.
Sorgi
P J
PJ
Ratey
J J
JJ
Polakoff
S
S
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000374:Aggression / Q000187:drug effects*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009248:Nadolol; D011412:Propanolamines / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009248:Nadolol; D011433:Propranolol